- Methodology article
- Open Access
A simplified, robust, and streamlined procedure for the production of C. eleganstransgenes via recombineering
© Zhang et al; licensee BioMed Central Ltd. 2008
Received: 13 May 2008
Accepted: 30 December 2008
Published: 30 December 2008
The nematode Caenorhabditis elegans has emerged as a powerful system to study biologic questions ranging from development to aging. The generation of transgenic animals is an important experimental tool and allows use of GFP fusion proteins to study the expression of genes of interest or generation of epitope tagged versions of specific genes. Transgenes are often generated by placing a promoter upstream of a reporter gene or cDNA. This often produces a representative expression pattern, but important exceptions have been observed. To better capture the genuine expression pattern and timing, several investigators have modified large pieces of DNA carried by BACs or fosmids for use in the construction of transgenic animals via recombineering. However, these techniques are not in widespread use despite the advantages when compared to traditional approaches. Additionally, some groups have encountered problems with employing these techniques. Hence, we sought identify ways to improve the simplicity and reliability of the procedure.
We describe here several important modifications we have made to existing protocols to make the procedure simpler and more robust. Among these are the use of galK gene as a selection marker for both the positive and negative selection steps in recombineering, the use of R6K based plasmids which eliminate the need for extensive PCR product purification, a means to integrate the unc-119 marker on to the fosmid backbone, and placement of homology arms to commonly used GFP and TAP fusion genes flanking the galK cassette which reduces the cost of oligos by 50%.
We have made several significant changes that allow the production of C. elegans transgenes from a commercially available fosmid library in a robust and streamlined manner. These changes make the technique more attractive especially to small academic labs unfamiliar with recombineering.
The generation of transgenic animals in model systems such as Caenorhabditis elegans has created dramatic changes in the ability of researchers to approach biologic questions . It is relatively straightforward to create and use a transgenic animal to investigate the timing and pattern of gene expression, express epitope-tagged versions of genes, or test the effects of gene mis-expression.
Traditionally, constructs used for creation of a GFP fusion gene or epitope-tagged version of a gene were drawn from regions of cloned genomic DNA which were known to rescue mutants of the specific gene . As the availability of RNAi, microarrays, and other approaches which are based upon the worm genomic sequence instead of classical mutants has increased, a need to create transgenes in other ways has developed. For these genes, a region 5' of the gene is often isolated via PCR and then used as a promoter [2, 3]. This approach has been further simplified by the construction of a large number of vectors by the Fire lab and later by the generation of the C. elegans promoterome [1, 2, 4, 5]. However, the decision about the exact length and location of the promoter is more often driven by arbitrary decisions about the size (i.e. 2–3 kb) or convenient restriction sites than sequence analysis. As a result, it is difficult to know if the GFP expression pattern created by a selected promoter reflects the true expression pattern of the gene in vivo .
To generate transgenes that are more likely to reflect the in vivo expression timing and pattern, interest in generating transgenics using the larger regions of genomic DNA carried by either fosmids or BACs (bacterial artificial chromosomes) is growing [5–7]. This approach carries the advantage of using 30–300 kb of genomic DNA in the construction of a transgene so it is likely that all or most of the promoter and enhancer elements are included. Additionally since the genomic DNA for the gene is included, additional complexities such as alternative splicing, multiple transcription start sites, and regulation by 3' UTR sequences or microRNA can also occur.
For this approach to become a standard technique within the C. elegans community, approaches need to be developed to make the modification of fosmids and BACs quick and robust for the novice. Two recent publications have begun to lay the groundwork for this to occur [6, 7]. The first described the modification of C. elegans fosmids using homologous recombination in E. coli (recombineering) using PCR generated DNA fragments . The creation of a transgene occurred through a two-step procedure where first a tetA-rpsL cassette (RT cassette) flanked by homology arms is inserted at the desired location and then in a second step the cassette is replaced by the desired DNA, such as GFP, flanked by the same homology arms. This technique allows the insertion of essentially any sequence at any site in the gene. The second paper described the modification of BACs from the related nematode species Caenorhabditis briggsae also by the use of recombineering . In this protocol, a GFP fusion gene is created by inserting GFP at the C-terminus of a gene of interest along with a flanking kanamycin resistance cassette via a single round of recombineering with a PCR product flanked by homology arms. The BAC is also prepared for use as a transgene by insertion of the unc-119 gene via recombineering. The addition of the unc-119 gene provides an easily visualized selectable marker as this DNA is able to rescue the size, body shape, mobility, and starvation resistance defects present in unc-119 mutants . Each approach has strengths and weaknesses for the routine generation of transgenic worms .
We have furthered their work by developing a streamlined series of procedures and accompanying vectors to allow the simple and reliable generation of transgenes ready for the transformation of worms by bombardment or microinjection. Specifically, we focused on the use of C. elegans genomic DNA cloned into a commercially available fosmid library (Geneservice Ltd., Cambridge, UK). We then developed tools that will allow the robust and efficient generation of either FLAG-GFP or TAP fusion genes by four important changes. First, we utilized the more robust galK gene for positive and then negative selection during recombineering . Second, we constructed plasmids for galK utilizing the R6K origin which is unable to replicate in the E. coli strain used for recombineering and minimizes the amount of processing of the PCR products used . Third, we built homology arms for both GFP and N and C-terminal TAP tags into the galK cassette so that a single pair of oligos can be used for the generation of PCR products for each step. The oligos used for recombineering are long and require purification prior to use so the need for one pair instead of two reduces either the labor or cost involved in procuring the oligos. Finally, we developed a protocol for adding the unc-119 gene to the fosmid backbone through cre-lox mediated recombination . The final fosmid product can then be used directly for the generation of transgenic nematodes.
We sought to use the C. elegans fosmid library and recombineering for the routine generation of transgenes and subsequent creation of transgenic worms. Two techniques have been described using recombineering in C. elegans with one using a BAC library generated from the related nematode species C. briggsae while the other used the fosmid library followed by microinjection of the modified plasmids [6, 7]. We initially used the protocol described by Dolphin et. al. to successfully generate several daf-12 transgenes (data not shown) (Additional files 1, 2, and 3). During this process we identified several ways to optimize and simplify the protocol for recombineering and transgenic animal creation.
The plasmid template used for the generation of the selection/counter-selection cassette by PCR, pBAC-RT, is able to replicate in the SW106 bacterial strain used for recombineering. Consequently, this template needs to be destroyed prior to electroporation either by DpnI digestion or as suggested by Dolphin et. al. through the use of a restriction fragment as the PCR template . As pBAC-RT is constructed on a BAC vector backbone, it is a very low copy number plasmid, and we experienced difficulty in purifying sufficient DNA to digest and gel purify the fragment containing the RT cassette. To address this difficulty, we subcloned the RT cassette from pBAC-RT into the pMOD4 vector (Epicentre Biotechnologies, Madison, WI). pMOD4 uses the R6K replication origin which requires the π protein for replication in E. coli. The resulting plasmid pMOD4 RT has the advantages of having a higher copy number than pBAC-RT which simplifies DNA purification and of being unable to replicate in the SW106 bacterial strain. Even when >100 ng. of pMOD4 RT DNA was electroporated into SW106 no tetR colonies were obtained (data not shown). As a result, PCR products used for recombineering do not need to be digested with DpnI or be extensively purified prior to use.
During the construction of pMOD4 RT and daf-12 transgenes using the RT cassette we found two limitations of the RT cassette. First, the RT cassette appears to be somewhat toxic to E. coli as pMOD4 RT could only be maintained in the JM109λpir strain where it is a low copy number plasmid instead of the EC100pir-116 strain which increases the copy number of R6K based plasmids to ~250. This toxicity may contribute to some of the difficulties we experienced with positive and negative selection of fosmids carrying the cassette. Second, the RT cassette involves separate genes for positive and negative selection during recombineering . This property may increase the background during negative selection as mutations in the gene involved would be silent until the bacteria are plated on selective media . These mutations are most likely introduced during PCR amplification as 106 amplification of the template would be expected to produce ~2–6% of products with mutations for proofreading polymerases and up to 25% for Taq-proofreading polymerase blends . Hence, any toxicity of the cassette would facilitate selection of mutated, less toxic clones. To address these two concerns we experimented with the use of the galK gene for positive and negative selection during recombineering . To facilitate the use of galK, we transferred the galK gene to the pMOD4 plasmid and added GFP homology arms for use during recombineering (Figure 1, Additional files 1, 2, and 3).
Genotype of colonies isolated after recombineering
PCR product electroporated
GFP + colonies
Cassette + colonies
(Frozen 1 year)
(Frozen 1 year)
The source of this difference appears to be at least in part due to weaker negative selection from the RT cassette as revealed by analysis of colonies obtained after a no PCR product control electroporation. This control was conducted similarly to the second recombineering step but no FLAG-GFP PCR product was added prior to electroporation. PCR analysis of 48 colonies for the galK and RT cassettes revealed that 23/48 galK cassette bacteria still had at least part of the cassette whereas 46/48 RT colonies still had a cassette detectable by PCR (Table 1). This suggests that a significant number of bacteria with the RT cassette are still able to grow despite negative selection. Further, addition of the FLAG-GFP PCR product to the electroporation resulted in a noticeable increase in colonies from bacteria with the galK cassette but not from bacteria with the RT cassette (Table 1). These counts were performed in parallel and included bacteria from undiluted, 1:10 diluted, and 1:100 diluted samples plated from a single experiment. Together, the greater number of total colonies obtained from bacteria with the galK cassette along with the more effective negative selection might lead to the greater effectiveness of the galK cassette in recombineering as the significant number of true positives could now outnumber the relatively small number of false positives. Consistent with this, PCR analysis of the galK colonies electroporated with the FLAG-GFP PCR product revealed that only 3/48 colonies retained the galK cassette whereas 40/48 colonies correctly have the FLAG-GFP tag instead.
A streamlined procedure for transgene production
We describe a modified protocol and accompanying vectors that can be used to easily produce fosmid-based transgenes for the generation of transgenic C. elegans. Our protocol involves three steps which are all carried out in the SW106 bacterial stain.
In the first step, the galK gene is integrated into the desired site in the fosmid to be modified through recombineering with a PCR product carrying galK flanked by homology arms complementary to the target fosmid (Additional files 1, 2, and 3). We have improved this step relative to prior techniques via the integration of homology regions for either FLAG-GFP or a TAP tag into the galK cassette. This allows a single set of oligos to be used for the first and second steps of fosmid modification and lowers the cost of fosmid modification by 50%. The integration of GFP homology arms into the RT cassette has also been recently described by Bamps and Hope . This modification is especially important if the technique is to be scaled up to genome-wide coverage. We further simplify the first step through the use of a galK cassette carried on an R6K-based vector which is unable to replicate in the SW106 bacterial strain. This improvement eliminates the need to either DpnI digest nor extensively purify the PCR product used for recombineering.
In the second step, the galK cassette is replaced with tags such as GFP or TAP which are then fused with the gene of interest on the fosmid (Additional files 1, 2, and 3). The success of this step hinges on the effectiveness of the negative selection strategy used to identify correctly modified fosmids from those that are unmodified. We found that the galK cassette was more reliable than the previously described RT cassette in head to head testing. Similar results have also been found by another lab (P. Moroni, personal communication). This may be due to the galK gene product serving as the target of both positive and negative selection instead the two separate genes in the RT cassette which are involved in each step . The larger size of the RT cassette also required the use a lower fidelity polymerase, i.e. a Taq/proof-reading polymerase versus a proof-reading polymerase alone, for efficient amplification which may serve as a source of mutations in the cassette that could interfere with the negative selection step. Alternately, we have found that the RT cassette is somewhat toxic to bacteria which may lead to the selection for mutations that decrease the effectiveness of negative selection. In contrast, for the galK cassette the positive selection step and subsequent re-streaking on MacConkey agar select for robust galK expression before galK is used in the negative selection step. Additionally, our addition of the FLAG-GFP or TAP homology regions into the galK cassette may also increase the efficiency of recombineering by increasing the length of the homology arms the PCR product to a maximum of 100 bp on each end. However, we have failed to see a qualitative difference between the 100 bp homology arm and a shorter FLAG-GFP only PCR product with 50 bp homology arms when tested (data not shown). It still may be possible that for a subset of genes the 100 bp homology arms might make an important contribution. Finally, it may be possible that subtle changes in the protocol used by other groups may have a significant impact on the success of recombineering with the RT cassette as some groups have reported higher efficiency rates with it .
In the third step a selectable marker for the generation of transgenic worms is added to the fosmid (Additional files 1, 2, and 3). This creates a marker in cis and directly linked to the modified fosmid. For the selectable marker, we chose the widely used unc-119 marker that is compatible with both microinjection and biolistic bombardment . Bombardment is particularly useful as significant numbers of transgenic lines can be generated by a single trial and even inexperienced personnel can create transgenics (data not shown).
As a result of our modifications, the entire procedure can be accomplished from start to production of a transgenic animal in a few weeks even by members of the lab who have a grasp of lab basic techniques but are not expert in molecular biology or microbiology.
Our lab has used this procedure to generate both GFP transgenes to examine gene expression pattern and response to RNAi . We have also used this procedure to generate TAP transgenes for proteomic studies, but these transgenic animals could also be used for chromatin or RNA immunoprecipitation assays as well (Figure 6 and not shown). It might be possible to adapt this technique to liquid culture as means to create transgenes in a high throughput manner. Beyond the intended uses of this technique, we have found that recombineering provides the flexibility to generate alternate vectors at a later time. Specifically, the induced, competent bacteria carrying the galK intermediate can be stored for later use even months to a year later (Table 1). Oligos carrying homology arms to the target gene can then be used to quickly add other tags generated by PCR. For example, we have been able to generate a transgene carrying a modified TAP tag which has been reported to produce higher purified protein yields in Drosophila to conduct head-to-head tests . Making this change only requires a few days of work to reach the stage of generating new transgenic animals. Finally while our work focused on applications in C. elegans, it is likely that some of these reagents can be used in the construction of modified BACs or fosmids for other experimental systems.
During construction of modified fosmids, we encountered problems with the modification of srp-6 and dod-22. These fosmids are similar in that both contain multiple genes that are highly similar at the sequence level. For example, the WRM0627aH02 fosmid contains both srp-5 and srp-6 and the WRM066cB09 fosmid contains dod-22 and K10D11.2. For srp-6 we discovered a rearrangement during the initial transformation into SW106. This was easily detected via PCR using primers that anneal 50–100 nucleotides away on the genomic sequence flanking the desired modification site. For dod-22 we found that the galK cassette integrated into another site on the fosmid. This was similarly detected by PCR using flanking oligos. Both of these difficulties could be overcome by diligence during the screening of isolated colonies and are likely due to the presence of highly similar sequences that could lead to spurious recombination events. To guard against moving forward with an incorrect fosmid, we have routinely screened colonies with both cassette-specific and flank sequence-specific oligos to ensure the right insert and right site. The flanking oligos are also useful for the sequencing of the resulting fosmids.
We have modified existing recombineering protocols to create a simpler and more robust method of generating transgenes for use in the construction of transgenic worms. The approach and vectors will be of benefit especially to smaller academic labs looking to begin to use fosmid-based transgenes.
Strain and vector availability
Cloning Vector Collection
pBAC-RT was obtained from Dr. Colin Dolphin . pMOD4-RT was generated by digesting pBAC-RT with EcoRI and ApaI and ligating this fragment into pLoxP. The resulting plasmid was digested with XbaI and EcoRI and the fragment carrying the RT cassette was ligated into pMOD4 (Epicentre Biotechnologies, Madison, WI) (Table 2). pMOD4-RT could only propagated in JM109λpir where the plasmid is low copy number. pMOD4-RT-G was created from pMOD4-RT by insertion of oligos containing 50 bp regions of homology to the N and C-terminal ends of FLAG-GFP (sequence available on request). This resulted in an RT cassette that was slightly larger than that generated via PCR by Dolphin et. al. . pMOD4 galK-G was constructed from pGalK (a gift of Drs. Soren Warming and Neal Copeland) by insertion of oligos containing 50 bp regions of homology to the N and C-terminal ends of FLAG-GFP into the plasmid (sequence available on request). The oligos and galK cassette were then removed as an XbaI-Acc65I fragment and ligated into pMOD4 digested with XbaI and Acc65I. pMOD4 galK-GT was constructed from pMOD4 galK-G by insertion of oligos containing 50 bp regions of homology to the N and C-terminal ends of the N and C-terminal TAP tags from the plasmids pBS1761 and pBS1479, respectively (Table 2) [20, 23]. pMOD4 GFP was generated by cloning a PstI-EcoRI fragment from pFLAG-GFP Daf-12 into pMOD4 digested with PstI and EcoRI. This fragment contains a 5' FLAG epitope fused to GFP from pPD117.01 (a gift from Dr. Andy Fire) and the N-terminal 328 amino acids of daf-12 (Table 2). pLoxP unc-119 was generated by inserting an oligo containing a loxP site into pMOD4 (sequence available on request) and digesting the resulting plasmid with XbaI and ApaI. The unc-119 gene was excised from pDP#MM016b as an XbaI-ApaI fragment and inserted into pLoxP (Table 2) .
The following fosmids were obtained from Geneservice Ltd. (Cambridge, UK): WRM066cB09 – dod-22, WRM0615cC09 – K10C2.4, WRM061015 – myo-3, WRM0627aH02 – srp-6 (Table 2).
Electrocompetent SW106 cells were made by growing a 5 mL overnight culture in LB broth with chloramphenicol (12.5 μg/mL) (Additional files 1, 2, and 3). 1 mL was then inoculated into 100 mL of LB with chloramphenicol in a 2 L flask and grown to an OD600 0.6–0.8. 50 mL of the culture was then transferred to a sterile 250-mL flask and induced by gently shaking (100 rpm) in a water bath at 42°C for 20 minutes. In control experiments we found that use of a shaking water bath was critical for effective induction. These can be often purchased used for much less than new equipment. The non-induced control was shaken gently for the same amount of time at 32°C, and then both cultures were incubated on ice for 15 minutes. Each culture was then pelleted and washed twice in 50 mL ice-cold 10% glycerol. All but ~500 μl of each supernatant was aspirated and the pellets were resuspended by gentle vortexing. 100 μl aliquots were then stored at -80°C until use.
Oligonucleotides used for PCR
C-term TAP F
C-term TAP R
N-term TAP F
N-term TAP R
RT screen F
RT screen R
For the second recombineering process, PCR-generated fragments from pMOD4 FLAG-GFP, pBS1761 (N-term TAP), or pBS1479 (C-term TAP) were generated using the same oligos used in the first round or using shorter GFP or TAP-specific oligos (Table 3). The products (100 ng.) were electroporated into induced competent SW106 cells prepared as above. The electroporation was done as above, except bacteria containing the RT cassette were recovered in SOC and plated on NSLB agar plates containing chloramphenicol (12.5 μg/mL) and streptomycin (500 μg/mL) and those containing the galK cassette on MOPS minimal media plates containing 0.2% 2-deoxy-galactose (DOG) and 0.2% glycerol in addition to leucine (45 mg/L), biotin (1 mg/L), and chloramphenicol (12.5 μg/mL) . The plates were incubated for 3–5 days. While we followed relative colony counts on the induced and un-induced plates, we found that there was not always a direct correlation between the counts and successfully identifying clones with correctly modified fosmids. 4 colonies were used to make 5 mL overnight cultures in LB with chloramphenicol (12.5 μg/mL) and these were used for colony PCR as above to confirm that the cassette was inserted. DNA sequencing using flanking oligos was also used to verify correct modification of the fosmid.
Addition of the unc-119 selectable marker
To facilitate the identification of transgenic worms following biolistic transformation, we inserted the unc-119 gene into the fosmid backbone via cre-lox mediated recombination using the pLoxP unc-119 plasmid (Additional files 1, 2, and 3) [11, 24]. pLoxP unc-119 carries the unc-119 gene on a R6K-based suicide vector that is unable to replicate in the SW106 bacteria (data not shown). Recombination was accomplished by preparing competent SW106 bacteria carrying the modified fosmid followed by electroporation with 50 ng. pLoxP unc-119 as described above. Following electroporation, bacteria were allowed to recover in LB containing 0.1% arabinose for 1 hour. Aliquots were plated on LB plates containing ampicillin (50 μg/mL) and chloramphenicol (12.5 μg/mL) which selects for integration of pLoxP into the fosmid. The presence of the unc-119 gene could also be verified via PCR (Table 3 and Figure 3).
Generation of transgenic worms
Fosmids modified through two rounds of recombineering and addition of the unc-119 gene were isolated via mini-prep using the FosmidMAX DNA purification kit (Epicentre Biotechnologies, Madison, WI). This DNA was used to electroporate the EPI300 bacterial strain which allows library fosmids to be amplified by following the manufacturer's instructions (Epicentre Biotechnologies, Madison, WI). Amplified fosmids were purified from 50 mL of culture using the same kit. We also used a Qiagen maxi-prep kit (Qiagen Inc., Valencia, CA) but found significant amounts of sheared DNA compared with the FosmidMAX kit (not shown). 10 ug of fosmid DNA was used to transform the DP38 unc-119(ed3) mutant strain via gold microparticle bombardment using a published protocol . Transgenic animals were identified via the rescue of the unc-119 mutation by the rescue fragment carried on the fosmid.
RNAi treatment was conducted using the feeding approach. The K10C2.4 and GFP RNAi constructs have been previously described [14, 26]. Photomicrographs were taken using an Olympus BX51 upright microscope fitted with FITC filters for detection of GFP. All photos were taken on the same day using the same camera settings to allow direct comparison of images. Western blotting was performed on worm extracts as previously described . Detection was performed using the anti-FLAG antibody (Sigma-Aldrich, St. Louis, MO) followed by incubation with an IR dye 800 donkey anti-mouse secondary antibody (Li-Cor Biosciences, Lincoln, NE). Equal loading was confirmed by use of an anti-actin antibody as previously described .
We wish to thank Drs. S. Warming and N. Copeland for providing the SW106 bacterial strain and pGalK plasmid used in this work, Dr. C. Dolphin for providing the pBAC-RT plasmid and help with getting started with recombineering, and Dr. P. Moroni for helpful discussion.
This work was funded by NIH grant AG028977 to ALF and in part by a pilot project grant from the University of Pittsburgh OAIC (AG024827). The funding agencies played no role in the collection, analysis, or reporting of results.
- Mello C, Fire A: DNA transformation. Methods Cell Biol. 1995, 48: 451-482.View ArticlePubMedGoogle Scholar
- Fire A, Harrison SW, Dixon D: A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans. Gene. 1990, 93: 189-198.View ArticlePubMedGoogle Scholar
- Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC: Green fluorescent protein as a marker for gene expression. Science. 1994, 263: 802-805.View ArticlePubMedGoogle Scholar
- Dupuy D, Li QR, Deplancke B, Boxem M, Hao T, Lamesch P, Sequerra R, Bosak S, Doucette-Stamm L, Hope IA, Hill DE, Walhout AJ, Vidal M: A first version of the Caenorhabditis elegans Promoterome. Genome Res. 2004, 14: 2169-2175.View ArticlePubMed CentralPubMedGoogle Scholar
- Bamps S, Hope IA: Large-scale gene expression pattern analysis, in situ, in Caenorhabditis elegans. Brief Funct Genomic Proteomic. 2008Google Scholar
- Dolphin CT, Hope IA: Caenorhabditis elegans reporter fusion genes generated by seamless modification of large genomic DNA clones. Nucleic Acids Res. 2006, 34: e72-View ArticlePubMed CentralPubMedGoogle Scholar
- Sarov M, Schneider S, Pozniakovski A, Roguev A, Ernst S, Zhang Y, Hyman AA, Stewart AF: A recombineering pipeline for functional genomics applied to Caenorhabditis elegans. Nat Methods. 2006, 3: 839-844.View ArticlePubMedGoogle Scholar
- Praitis V, Casey E, Collar D, Austin J: Creation of low-copy integrated transgenic lines in Caenorhabditis elegans. Genetics. 2001, 157: 1217-1226.PubMed CentralPubMedGoogle Scholar
- Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG: Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 2005, 33: e36-View ArticlePubMed CentralPubMedGoogle Scholar
- Penfold RJ, Pemberton JM: An improved suicide vector for construction of chromosomal insertion mutations in bacteria. Gene. 1992, 118: 145-146.View ArticlePubMedGoogle Scholar
- Kotzamanis G, Cheung W, Abdulrazzak H, Perez-Luz S, Howe S, Cooke H, Huxley C: Construction of human artificial chromosome vectors by recombineering. Gene. 2005, 351: 29-38.View ArticlePubMedGoogle Scholar
- Stavropoulos TA, Strathdee CA: Synergy between tetA and rpsL provides high-stringency positive and negative selection in bacterial artificial chromosome vectors. Genomics. 2001, 72: 99-104.View ArticlePubMedGoogle Scholar
- Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Ishioka C, Friend SH, Iggo R: A rapid PCR fidelity assay. Nucleic Acids Res. 1994, 22: 3259-3260.View ArticlePubMed CentralPubMedGoogle Scholar
- Fisher AL, Page KE, Lithgow GJ, Nash L: The Caenorhabditis elegans K10C2.4 Gene Encodes a Member of the Fumarylacetoacetate Hydrolase Family: A CAENORHABDITIS ELEGANS MODEL OF TYPE I TYROSINEMIA. J Biol Chem. 2008, 283: 9127-9135.View ArticlePubMed CentralPubMedGoogle Scholar
- Cheeseman IM, Niessen S, Anderson S, Hyndman F, Yates JR, Oegema K, Desai A: A conserved protein network controls assembly of the outer kinetochore and its ability to sustain tension. Genes Dev. 2004, 18: 2255-2268.View ArticlePubMed CentralPubMedGoogle Scholar
- Duchaine TF, Wohlschlegel JA, Kennedy S, Bei Y, Conte D, Pang K, Brownell DR, Harding S, Mitani S, Ruvkun G, Yates JR, Mello CC: Functional proteomics reveals the biochemical niche of C. elegans DCR-1 in multiple small-RNA-mediated pathways. Cell. 2006, 124: 343-354.View ArticlePubMedGoogle Scholar
- Polanowska J, Martin JS, Garcia-Muse T, Petalcorin MI, Boulton SJ: A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites. EMBO J. 2006, 25: 2178-2188.View ArticlePubMed CentralPubMedGoogle Scholar
- Luke-Glaser S, Roy M, Larsen B, Le BT, Metalnikov P, Tyers M, Peter M, Pintard L: CIF-1, a shared subunit of the COP9/signalosome and eukaryotic initiation factor 3 complexes, regulates MEL-26 levels in the Caenorhabditis elegans embryo. Mol Cell Biol. 2007, 27: 4526-4540.View ArticlePubMed CentralPubMedGoogle Scholar
- Audhya A, Desai A: Proteomics in Caenorhabditis elegans. Brief Funct Genomic Proteomic. 2008Google Scholar
- Rigaut G, Shevchenko A, Rutz B, Wilm M, Mann M, Seraphin B: A generic protein purification method for protein complex characterization and proteome exploration. Nat Biotechnol. 1999, 17: 1030-1032.View ArticlePubMedGoogle Scholar
- Gottschalk A, Almedom RB, Schedletzky T, Anderson SD, Yates JR, Schafer WR: Identification and characterization of novel nicotinic receptor-associated proteins in Caenorhabditis elegans. EMBO J. 2005, 24: 2566-2578.View ArticlePubMed CentralPubMedGoogle Scholar
- Yang P, Sampson HM, Krause HM: A modified tandem affinity purification strategy identifies cofactors of the Drosophila nuclear receptor dHNF4. Proteomics. 2006, 6: 927-935.View ArticlePubMedGoogle Scholar
- Puig O, Caspary F, Rigaut G, Rutz B, Bouveret E, Bragado-Nilsson E, Wilm M, Seraphin B: The tandem affinity purification (TAP) method: a general procedure of protein complex purification. Methods. 2001, 24: 218-229.View ArticlePubMedGoogle Scholar
- Maduro M, Pilgrim D: Identification and cloning of unc-119, a gene expressed in the Caenorhabditis elegans nervous system. Genetics. 1995, 141: 977-988.PubMed CentralPubMedGoogle Scholar
- Berezikov E, Bargmann CI, Plasterk RH: Homologous gene targeting in Caenorhabditis elegans by biolistic transformation. Nucleic Acids Res. 2004, 32: e40-View ArticlePubMed CentralPubMedGoogle Scholar
- Timmons L, Court DL, Fire A: Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene. 2001, 263: 103-112.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.